Skip to content

Comparison of the therapeutic effects of Bushen Tongluo recipe granules and decoction pieces on diabetes nephropathy based on intestinal mucosal barrier

Comparison of the therapeutic effects of Bushen Tongluo recipe granules and decoction pieces on diabetes nephropathy based on intestinal mucosal barrier

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063704
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes nephropathy

Interventions

Group 2:
Group 1 :

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Outpatients and inpatients who meet the diagnostic criteria of diabetes nephropathy (DKD), are aged between 40-70 years (including 40 and 70 years), and can be followed up for a long time, shall sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who have received renal replacement therapy (kidney transplantation, hemodialysis, peritoneal dialysis, etc.), combined with serious life-threatening primary diseases such as liver, kidney, cardiovascular and cerebrovascular diseases, and hematopoietic system, and patients with mental illness, pregnant or breastfeeding patients, those with allergies or allergies to this drug, and those with primary or other secondary glomerular diseases or tumors.

Design outcomes

Primary

MeasureTime frame
urinary microalbumin excretion rate;

Secondary

MeasureTime frame
serum creatinine;blood urea nitrogen;

Countries

China

Contacts

Public ContactCunyun Min

Guangdong Provincial People's Hospital

mcy1288@163.com+86 13829717458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026